Arkamin® Tablets

Clonidine 100mcg

USD $19.80 (EUR €18.81)

Arkamin® Tablet Clonidine 100mcg is an alpha-2 agonist. It works by relaxing blood vessels which makes the heart more efficient at pumping blood around the body.

This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine CHL belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.

Size: 60 Tablets
Brand name: Kapvay, Catapres
Title Range Discount
Items: 2 - 4 5%
Items: 5 - 8 10%
Items: 9 + 15%
Category:

Description

What is Arkamin® Tablet Clonidine 100mcg?

Arkamin® Tablet is a medicine used in the treatment of hypertension (high blood pressure). It lowers blood pressure by relaxing the blood vessels. Lowering the blood pressure helps to prevent future stroke and heart attack.

Clonidine is a type of drug known as an alpha-2 adrenergic agonist. The Food and Drug Administration (FDA) has approved it to treat both high blood pressure and ADHD, but doctors may also prescribe it for other, off-label indications.

Doctors classify clonidine as a nonstimulant, making it a second-line ADHD medication. Therefore, they may recommend using clonidine to help treat the symptoms of ADHD in people who do not respond well to or cannot take stimulants. They may also suggest that people with severe symptoms of ADHD take clonidine alongside stimulants.

Clonidine stimulates alpha-adrenergic receptors in the brain, which lowers the heart rate and relaxes the blood vessels, lowering blood pressure. In people with ADHD, clonidine may affect the part of the brain controlling attention and impulsive behavior, but its exact mechanism is still unknown.

Arkamin® Tablet is also used to prevent migraines and hot flushes in women during menopause. This medicine can be taken with or without food but it is better to take it at the same time every day. You should always take this medicine as advised by the doctor and should never stop it without consulting the doctor. Most people with high blood pressure do not feel ill, but if you stop taking this medicine, your condition could get worse. This may lead to your blood pressure rising up again and increase your risk of heart disease and stroke. You should monitor your blood pressure regularly while taking this medicine.

Common side effects of this medicine include dizziness, headache, nausea, fatigue, dry mouth, constipation, insomnia. Consult your doctor if these side effects bother you. Before taking this medicine, it is better to let your doctor know if you are suffering from any kidney or liver disease. Also, pregnant women and breastfeeding mothers should consult a doctor before taking it.

In Treatment of Hypertension (high blood pressure). Arkamin® Tablet works by relaxing the blood vessels so that blood can flow more easily around your body. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.

Although clonidine was originally a medication to control blood pressure, it may be a useful treatment for managing ADHD symptoms. Doctors classify it as a nonstimulant medication for ADHD. A doctor may recommend clonidine to replace a stimulant drug or advise a person to take it alongside a stimulant.

Researchers are still uncertain exactly how clonidine helps treat ADHD, but it may work by acting on the part of the brain that influences inattentiveness, hyperactivity, and impulsivity. People can work with their doctor to find the correct medication and dosage to help treat their ADHD symptoms.

Reviews

There are no reviews yet.

Be the first to review “Arkamin® Tablets”

Your email address will not be published.